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ABSTRACT This paper presents an analysis of networks among small and medium-sized enterprises
in the Irish biotech sector. The study applies social network analysis to determine the structure of
networks of company directors and inventors in the biotech sector. In addition, on the basis of
interviews, this article analyses the extent of actual knowledge flow through these industry
networks. The paper makes both a theoretical and methodological contribution to innovation
network research. In relation to theory, the findings of the social network analysis indicate that
the extent and path of knowledge flow are influenced by both the type of knowledge in question
and whether the network is of a formal or informal nature. Methodologically, the results of this
paper raise questions about the application of social network analysis in innovation studies.
Introduction
Recent studies of innovation detail how innovation processes are becoming increasingly
complex. Individual firms can no longer rely on their internal sources of knowledge
alone. Instead additional knowledge needs to be accessed from external sources. The
paradigm of slowly evolving networks of organizations has come to be replaced by
more fluid, amorphous and transitory structures based on alliances, partnerships and
collaborations. These trends have been characterized as a transition towards “open
innovation” (Chesborugh, 2003) and “distributed knowledge networks” (Asheim et al.,
2007). These ideas are also prominent in territorial economic development approaches
such as clusters (Porter, 1990) and national/regional system of innovation (Lundvall
et al., 2002; Edquist, 2006; Cooke, 2001). These approaches emphasize the collective,
collaborative processes that underlie innovation. They share a common interest in relations
and networks, and the way in which these features support knowledge flow (Ingstrup
et al., 2009).
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One strand of this research on innovation and territorial economic development has in
recent times advocated the application of social network analysis, one of the dominant tra-
ditions in network theory (Grabher, 2006), to empirical studies in this field. This tradition
has developed a range of conceptual devices, or frameworks, for analysing network struc-
tures, which can facilitate an analysis of regional innovation systems. For example,
“small-world analysis” can provide important insights into the structure of the networks
and their ability to support knowledge flows. One of the limitations of this type of analysis
is, however, that the observed network structures are in many cases only suggestive of
knowledge flow. What often remains unclear is how much actual knowledge flows
through these networks, the paths involved and how these flows are influenced by
network and knowledge characteristics. It is therefore important to investigate what
flows across the links and the nature of this knowledge flow (Grabher, 2006).
This paper sets out to explore and explain the structures of knowledge flow and inno-
vation among small and medium-sized enterprises (SMEs) in the Irish biotech sector.
The paper makes two core contributions, one theoretical and one methodological. Theor-
etically, the paper contributes to our understanding of the operation of innovation net-
works. In this regard, the study addresses two research questions:
(1) What are the structural characteristics of knowledge and innovation networks in the
Irish biotech sector and are these conducive to knowledge flow?
(2) How much knowledge actually flows across these networks, in what way and how is
the level of actual knowledge flow influenced by the types of network and knowledge
in question?
Secondly, with respect to the methodological contribution, the paper increases our insight
into the relation between social network analysis and actual knowledge flows. Finally, the
paper expands existing empirical knowledge about the extent and nature of knowledge
flows in Irish biotech networks with implications for network policy.
The research design involves a mixed methodology, involving quantitative social network
analysis and interviews. Social network analysis is applied to investigate the extent and
structure of different types of networks in the biotech industry. In addition, interviews
have been conducted with directors of biotech companies in Ireland to obtain more detailed
insights into the actual knowledge flows and the character of these flows.
The second section of this paper presents a discussion of network theory and introduces
a set of network and knowledge characteristics that are postulated to influence the extent
and nature of actual knowledge flows in innovation networks. This is followed by a dis-
cussion of the research design and methodology in the third section. The fourth section
introduces the biotech sector in Ireland. Next, the fifth section presents the findings of
the social network analysis, followed by an analysis of the actual knowledge flows in
the sixth section. The paper ends with conclusions and a discussion of the implications
for network policies.
Networks and Knowledge Flows
The roots of the network concept and network theory go back to the end of the nineteenth
century (Grabher, 2006). In broad terms, a network can be defined as a set of actors linked
through a specific type of connections (Grabher, 2006). For many years, little attention was
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devoted to the role of networks in economic activity but since the early 1990s an increas-
ing body of economists, economic sociologists and economic geographers have been
focusing on the role of networks in economic activity, innovation and regional develop-
ment. Network theory and analysis can lead to a better understanding of innovation and
territorial economic development processes (Ter Wal & Boschma, 2009).
A large strand of work on innovation and territorial economic development has applied
social network analysis, one of the dominant approaches/traditions in network theory
(Grabher, 2006). Social network analysis is based on the assumption of the importance
of relationships among interacting units or actors and on the belief that units do not act
independently but influence each other. Relational ties between actors are viewed as chan-
nels for transfer or flow of resources. “The unit of analysis is not the individual, but an
entity consisting of a collection of individuals and the linkages among them”. The
social network approach provides a precise method with which to define important
social concepts, a theoretical alternative to the assumption of independent social actors
and a framework for testing theories about structured social relationships (Wasserman
& Faust, 1994). As an analytical tool, social network analysis provides explicit formal
statements and measures of social structural properties. These tools facilitate the concep-
tualization of the interdependencies of behaviour and processes in networks. Structural
properties are formally conceptualized in terms of nodes and linkages and characterized
using “sociograms” and related measures of network structure.
Networks of relationships between social actors, be they individuals, organizations or
nations, have been used extensively over the last three decades as a means of representing
social metrics such as status, power and diffusion of innovation and knowledge (Watts,
1999; Kogut & Walker, 2001). Social network analysis has yielded measures both of
individual significance, such as centrality (Freeman, 1979), and of network efficiency or
optimal structure (Yamaguchi, 1994).
The tradition of social network analysis has developed a range of conceptual devices, or
frameworks, for analysing network structures that can facilitate an analysis of regional
innovation ecosystems. Among these, “small-world analysis” offers a means by which
we can gain insights into network structures and the role of these structures in facilitating
(or hindering) the flow of knowledge throughout the entire network. Knowledge is
assumed to flow most efficiently in networks with small-world characteristics. Where
small-world characteristics are absent, these can be created by adding a relatively small
number of remote links to the network where the level of local clustering is already
high (Grabher, 2006). Small-world analysis has been productively applied in the
context of biotech clusters. Casper and Murray (2005), for example, reported important
differences in the structure of the networks in the Cambridge and Munich biotech clusters.
Although small-world analysis provides important insights into the structure of the net-
works and their ability to support knowledge flow, the observed structures are in many
cases only suggestive of knowledge flow. They do not inform us about the extent and
characteristics of the actual knowledge flow, its strategic nature or the path that knowledge
takes through the network (Dahl & Pedersen, 2004). It is therefore important to investigate
what flows across the links, and in what way (Grabher, 2006). The remainder of this
section will discuss these ideas in more detail.
The extent of the actual knowledge flow is likely to depend on the type of network and
the type of knowledge. In relation to types of networks, a range of network forms and types
can be identified (see, for example, Grabher, 2006). A broad distinction can be made
Actual Knowledge Flow in the Irish Biotech Industry 1111
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between formal and informal networks.1 Formal networks are configured as inter-organ-
izational alliances while informal networks are based on inter-personal ties. In our
view, formal networks include both the longer-term strategic networks based on strategic
alliances and joint ventures, as well as the shorter term project networks distinguished by
Grabher (2006). Within these formal networks firms or institutions are linked in their total-
ity, via, for example, joint research projects or buyer–supplier agreements.
Informal networks, on the other hand, comprise of connected persons who principally
represent themselves. Because the persons are employed by firms and institutions, the
links between these persons indirectly also link the institutions. In this way, the individual
persons provide a pipeline for (informal) information flow between institutions. A large
variety of informal networks exist, including networks of former students, professional net-
works, networks of friends, members of sport clubs, networks of corporate board members
and so forth. Informal networks can develop on the back of, or evolve into, formal business
activity, as is the case with networks of former colleagues or former business relations that
have developed a friendship. However, the characteristic of such informal networks is
that the network is no longer based on these (former) formal relations. Informal networks
have different levels of organization or institutionalization. Some professional networks
(informal from the firms’ point of view) can be strongly institutionalized while other
networks, for example, those based on friendship are virtually unorganized.
Formal relations are likely to be more conducive to knowledge exchange, including
technical knowledge, due to the intensity of the relations. On the other hand, the intense
relations and the related knowledge flows are likely to be confined to discrete subgroups
involving relatively small number of actors. This makes them less conducive for knowl-
edge diffusion through the wider network. Disagreement exists as to the salience or impor-
tance of the informal knowledge exchange for the innovation capacity and competitiveness
of firms, as well as for regional clustering processes (Dahl & Pedersen, 2004). Some con-
tributions argue that informal networks are important channels for knowledge exchange,
and that individuals in different firms and institutions informally provide each other
with technical and market-related knowledge that can be of great value to the firm.
Others are of the view that, although informal knowledge exchange does occur, the knowl-
edge is generally of limited commercial or strategic value. Individuals will only exchange
general knowledge that is of relatively low value to the firm, for example, information
about job openings. In addition, the knowledge may not flow freely throughout the local
network but, instead, circulate in smaller (sub)communities.
In relation to the type of knowledge, a distinction has been made between know-why,
know-how and know-who type knowledge—with implications for the interplay between
actors in innovation networks (Asheim et al., 2007). Know-why knowledge relates to
natural systems and the applications of scientific laws. Know-how type knowledge
involved the more technical skills, often of a tacit nature. Finally, know-who type knowl-
edge involves knowledge about, for example, relevant business partners or sources of
finance. Van Egeraat et al. (2009), based on their work on innovation processes and
knowledge flows in the biotechnology industry, suggest adding a fourth, crucial, type
of knowledge to the categorization—market/business knowledge. This includes knowl-
edge of (unmet) market needs, the ability to connect particular inventions to market
needs, knowledge of regulatory procedures, knowledge of raising finance and so forth.
Know-why type knowledge tends to be more sensitive and can therefore be expected
to flow less easily through networks, notably informal networks. At the other end of
1112 C. van Egeraat & D. Curran
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the spectrum, know-who and market type knowledge is far less sensitive and is therefore
expected to flow more easily through networks of actors, including informal networks.
Another distinction in types of knowledge concerns the geographic content of the knowl-
edge. In relation to this, a broad distinction can bemade between knowledge about an actor’s
own country and knowledge about foreign countries. For example, knowledge about poten-
tial business partners at home versus knowledge about potential business partners abroad.
The geographic content of the knowledge should not be confused with the location of the
knowledge—local actors can be a source of knowledge about foreign locations. It is
expected that actors are better informed about potential business partners at home than
they are about potential business partners abroad and that the networks will play a different
role or be employed differently, depending on the geographic content of the knowledge.
Finally, in relation to the path of the knowledge flow, small-world analysis implies that
information will flow efficiently through the network, irrespective of the number of steps
involved. However, it remains unclear how far knowledge flows through the network
(Dahl & Pedersen, 2004). We can assume that the amount of information flow is
reduced with each step we become removed from the original source. In addition, the
path (number of steps) is likely to be partly determined by the type of knowledge.
Know-who and market type knowledge are expected to be exchanged across more steps
than know why/know how type knowledge. The remainder of this paper will explore
these ideas in the context of the Irish biotech industry. The next section begins by outlining
the methodology employed.
Methodology and Data Sources
This paper sets out to address two main research questions: (1) What are the structural
characteristics of knowledge and innovation networks in the Irish biotech sector and are
these conducive to knowledge flow? (2) How much knowledge actually flows across
these networks, in what way and how is the level of actual knowledge flow determined
by the type of network and knowledge?
The first research question has been addressed through quantitative social network
analysis. The tradition of social network analysis has developed a range of conceptual
devices, or frameworks, for analysing network structures that can facilitate an analysis
of regional innovation ecosystems. This research project focuses on “small-world”
network analysis. Small-world analysis is concerned with the density and reach of ties
between the actors in a given network. A small world is a network in which many
dense clusters of actors are linked by relationships that act as conduits of control and infor-
mation (Milgram, 1967; White, 1970). In keeping with the age-old exclamation “it’s a
small world!”, the idea is that this type of network allows any two actors to be connected
through a relatively small series of steps or links—despite the fact that the overall network
may be quite sparse and actors may be embedded in distinct clusters. As a result, actors in
the network may in reality be “closer” to each other than initially perceived.
These small-world networks, with high clustering and short global separation, have
been shown by Watts (1999) to be a general feature of sparse, decentralized networks
that are neither completely ordered nor completely random. Small-world network analysis
offers us a means by which we can gain insights into network structures and the role of
these structures in facilitating (or hindering) the flow of innovation and knowledge
throughout the entire network. Watts (1999) and Kogut and Walker (2001) advocate
Actual Knowledge Flow in the Irish Biotech Industry 1113
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comparing an observed network with a randomized network (i.e. a random graph) that has
the same number of actors (nodes) and same number of relationships (links) per actor as
the observed. Simulations by Watts (1999) show that the structural stability of small
worlds is retained even when a substantial number of relationships are replaced with ran-
domly generated links. The network becomes more globally connected rapidly but the
dense clusters are slow to dissolve. Thus, actors in the network can strategize and,
rather than being disrupted, the small-world structure is still replicated. In this way, net-
works that appear sparse can in fact contain a surprising degree of structure.
Small-world analysis has important application in the context of regional innovation
networks. Knowledge will flow most efficiently in networks with small-world character-
istics. Where small-world characteristics are absent, these can be created by adding a rela-
tively small number of remote links to the network where the level of local clustering is
already high (Grabher, 2006).
The formal description of small-world networks presented here is as per Watts (1999),
with the networks represented as connected graphs, consisting of undifferentiated vertices
(actors) and unweighted, undirected edges (relationships). All graphs must satisfy sparse-
ness conditions. The small-world network analysis that follows in the next section is
characterized in terms of two statistics:
Characteristic path length (L): The average number of edges that must be traversed
in the shortest path between any two pairs of vertices in the graph. L is a measure of
the global structure of the graph, as determining the shortest path length between any
two vertices requires information about the entire graph.
Clustering coefficient (C): If a vertex has kv immediate neighbours, then this neighbour-
hood defines a subgraph in which at most kv(kv 2 1)/2 edges can exist (if the neighbour-
hood is fully connected). Cv is then the fraction of this maximum that is realized in v’s
actual neighbourhood and C is this fraction averaged over all vertices in the graph. In
this way, C is a measure of the local graph structure.
In order to determine what is “small” and “large” in this analysis, Watts (1999) deter-
mines the following ranges over which L and C can vary:
(1) The population size (n) is fixed.
(2) The average degree k of vertices is also fixed such that the graph is sparse (k ,, n) but
sufficiently dense to have a wide range of possible structures (k .. 1).
(3) The graph must be connected in the sense that any vertex can be reached from any
other vertex by traversing an infinite number of edges.
Fixing n and k enable valid comparisons to be made between many different graph
structures. This also ensures that the minimum value for C is 0, while the maximum
value for C is 1. The sparseness condition ensures that while the network is sufficiently
well connected to allow for a rich structure, each element operates in a local environment
which comprises of only a tiny fraction of the entire system. Finally, the requirement that
the graph is connected guarantees that L is truly global statistic.
The analysis undertaken in this paper focuses on two distinct networks in the Irish bio-
technology industry: (i) the formal network of researchers and related companies and
(ii) the network of company directors. Formal networks of researchers have been the
subject of many previous studies, notably in the context of the biotech industry (Owen-
Smith & Powell, 2004, 2006; Coenen et al., 2006; Moodysson & Jonsson, 2007). Much
1114 C. van Egeraat & D. Curran
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of this research is based on patent data, although some studies are using survey data pro-
viding more detailed information about the type of knowledge flows. Networks of
company directors have been investigated in this paper as a form of informal networks.
Directors of biotech companies tend to hold directorships on numerous corporate
boards. Where this co-directorship concerns other biotech companies, the various links
can be taken to represent a conduit of knowledge flow between the respective companies.
Studies of corporate interlocks include Kogut and Walker (2001) and Davis et al. (2003).
Myint and Vyakarnam (2004) and Myint et al. (2005) investigate the corporate board
interlocks in the Cambridge biotech industry and reported the influential role of a select
number of “mini clusters” in the local network.
Data collection for this paper began with an inventorization of biotech companies in
Ireland (see the next section on the Irish biotech industry for details). Following this,
two separate data sets were compiled for our social network analysis of the Irish
biotech sector—a dataset on research networks structured by co-inventors and a set of
micro-data on co-directorships.
The first data set has been compiled from patent data available from the Irish Patent
Office (http://www.patentsoffice.ie/), US Patent and Trademark Office (http://www.
uspto.gov/), and Esp@cenet, the European Patent Office (www.espacenet.com). By
manual inspection of the patent filings of each Irish biotech company that has registered
patents, we established the researchers who worked on each patent, their employer at
the time and their location (whether they were foreign-based or located in Ireland).
In order to compile the second data set, a rigorous Internet search of official company
websites, media sources and the online Fame dataset has been conducted.2 In this way, it
can be ascertained whether a director of a given Irish biotech company also holds a direc-
torship with another Irish biotech company. Joint directorships are then taken to represent
a conduit of knowledge flow between the respective companies.3 We have endeavoured to
verify the database through consultation with industry experts. All data were analysed with
UCI-NET social network analysis software.
The second research question deals with the actual knowledge flows—how much
knowledge actually flows across the networks, in what way and how is the level of
actual knowledge flow determined by the type of network and knowledge? To address
this question, interviews were conducted with members of the two networks. The most net-
worked companies were identified on the basis of the findings of the social network analy-
sis and 10 were selected for interview. The interviewees were shown the sociograms and
invited to provide information regarding the knowledge flows (operating through the two
networks) with directly and indirectly linked firms and institutions. The semi-structured
questionnaire included questions regarding, amongst others: the type of knowledge (tech-
nical knowledge versus know who/market knowledge;4 geographical content of the
knowledge); the strategic importance of the knowledge (rated on a five-point Likert
scale); the actual persons in the companies involved in the link; the process of the knowl-
edge flow and the path of the knowledge (number of steps involved).
In addition, the interviews were used to obtain information about the extent of knowl-
edge exchange between the companies with all other biotech companies (irrespective
of whether or not these were identified in the sociograms related to the two networks).
For this purpose, the interviewees were shown a list of all biotech companies in Ireland
and asked to provide information regarding the knowledge flow. This part of the question-
naire involved the same set of questions as outlined above. The companies were asked to
Actual Knowledge Flow in the Irish Biotech Industry 1115
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provide information about both inward and outward knowledge flow. The interviews were
conducted with one director of each of the companies interviewed.
The Irish Biotech Industry
The development of the “modern” biotech sector5 in Ireland took off in earnest in the
1990s, although substantial employment growth only occurred in the 2000s due to the
establishment of a number of foreign-owned biopharmaceutical manufacturing plants.
The development of the indigenous industry has been shaped by two distinct evolutionary
processes (Curran et al., 2011). The industry has experienced a wave of private sector spin-
off firms emanating from Elan, Ireland’s largest indigenous biotech multinational, in the
aftermath of a US Securities and Exchange Commission investigation in 2002 into the
company’s accounting practices. Elan’s subsequent divesture of biotechnology assets
led to the formation of 12 spin-off firms during the period between 2002 and 2008 alone.
In parallel with this wave of Elan spin-offs, since the mid-1990s Ireland has benefited
from substantial public sector investment which has significantly enhanced the biotech
research performance of Irish universities (van Egeraat & Breathnacht, 2012; van
Egeraat & Barry, 2009). In 1998, the Irish government launched the Programme for
Research in the Third-Level Institutions (PRTLI) and Science Foundation Ireland (SFI),
which since its inception has invested E865 million (including exchequer and private
matching funds) into strengthening national research capabilities via investment in
human and physical infrastructure.6 In addition, a significant empowerment of Technology
Transfer Offices of the Irish universities has occurred over the last decade, in tandem with
a rapid realignment of university research activities (Geoghegan & Pontikakis, 2008).
Partly due to the lack of official statistics and partly due to the ambiguous nature of the
definition it is difficult to determine the size of the Irish biotech industry. Our “universe” of
firms in the modern biotech industry in Ireland was based on existing survey material
(InterTrade Ireland, 2003), the list of firms included on the “Biotechnology Ireland”
website (hosted by Enterprise Ireland), information from interviews with industry
experts and Internet search. The final list included 80 biotech firms. Biopharmaceuticals
and biodiagnostics are the largest subsectors with 64% of companies. The Irish biotech
sector includes 28 foreign-owned and 52 indigenous companies.
Nearly all the foreign-owned companies are subsidiaries of multinationals with a strong
manufacturing focus, although the biopharmaceutical manufacturing plants can have a
substantial process development component (van Egeraat, 2010). The indigenous compa-
nies are concentrated in biopharmaceuticals and biodiagnostics. However, the majority of
these firms are very small, early stage, start-up or campus companies. As regards company
size, the data are incomplete. What we do know is that all but two of the indigenous com-
panies are SMEs. It is estimated that the majority of indigenous companies on the list are
micro-enterprises, employing less than 10 staff. Most of the indigenous biopharmaceutical
companies are still at an embryonic stage, operating out of university labs and less than a
handful would have brought molecules beyond pre-clinical trials.
Structural Properties of Two Networks
Figure 1 presents a sociogram of the network connections in the Irish biotech industry,
using data on directorships. Some directors are director of more than one biotech
1116 C. van Egeraat & D. Curran
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company, providing links or ties in the network which can support information flow. This
sociogram is characterized by the presence of one distinct chain of companies linked to
each other through less than 10 directors. This chain of connected companies and promi-
nent directors exhibit strong “betweenness” centrality (Freeman, 1979) , as indicated in the
sociogram by the sizes of their nodes. Figure 2 presents a sociogram of the network con-
nections in the Irish biotech industry, but in this case the network of Irish biotech compa-
nies and researchers, as indicated by patent data. Unlike the directorship sociogram
(Figure 1), this patent-based sociogram is strongly influenced by the presence of one
central company, Elan, as well as a number of Elan’s subsidiaries. While a handful of indi-
vidual researchers do exhibit a degree of “betweenness” centrality, these individual
researchers are linked to only two or three biotech companies within the network.
On the face of it, the sociograms would suggest that the networks have a low density.
However, as discussed in the methodology section, the structure of the networks may
be such that despite low overall density, the small-world characteristics of short path
length and high clustering may still be features of the network. This would suggest that
rather than being a sparse network unsuited for swift flows of knowledge, there may actu-
ally be potential for rapid diffusion of knowledge through the network if the right actors
Figure 1. Network of Irish biotech directors and companies, based on directorship data.
Note: Rectangles indicate firms; circles indicate directors.
Actual Knowledge Flow in the Irish Biotech Industry 1117
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are targeted. Using both data sets, both informal networks and formal networks can be ana-
lysed and their conduciveness to knowledge flow compared. The results of the small-world
network analysis are now presented.
Table 1 presents the results from the Irish biotech network of directors and companies,
analysing the directors and companies separately (i.e. deconstructing a 2-node network
Table 1. Irish biotech industry directors and companies (via directorships) network
statistics
Variable Directors Companies
Density
Density (for all directors/firms) 0.018 0.016
Total no. of ties 1622 118
Average no. of ties (between those connected) 5.5 2.7
Clustering
Cluster coefficient 0.948 0.669
Random cluster coefficient 0.039 0.062
Path length
Average path length among those connected 3.538 2.912
Random average path length 3.127 4.111
Notes: No. of directors: 302; No. of firms: 86; No. of connected firms: 43.
Figure 2. Network of Irish biotech researchers and companies, based on patent data.
Note: Rectangles indicate firms; circles indicate directors. Light-shaded circles indicate researchers
based in Ireland, while dark-shaded circles indicate researchers based abroad.
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into its constituent 1-node networks). While directors may be connected to each other by
virtue of being on the board of the same company, this type of intra-company link is
avoided by analysing the company-only 1-node network. Thus, presenting the results of
both 1-node network analyses serves as a useful robustness check. In keeping with the
formal description of small-world networks presented in the methodology section, two
central findings can be gleaned from Table 1. First, it is clear that both directors and com-
panies are highly clustered (C ¼ 0.948 and 0.669, respectively). This is particularly
evident when compared with the low degree of clustering generated by a random
network with the same number of nodes and ties as the highly structured observed net-
works (C ¼ 0.039 and 0.062, respectively). Second, though the director and company net-
works are highly clustered, they are not characterized by long path lengths. This is in
keeping with Watts’ (1999) findings that even as a network moves from a structured to
a random graph, the path length decreases rapidly but the clustering is persistent
Comparable results emanating from the network of Irish biotech researchers and the
network of Irish biotech companies via patents are presented in Table 2. These results
refer to a formal network in the Irish biotech industry. Once again, the salient findings
are those of high clustering and short path lengths for both the researcher and company
networks. However, in this instance, the company network is noticeably less clustered
via patents than it was through directors. This result would suggest that, in keeping
with the postulation, this formal network is less conducive to knowledge flow than the
informal network of company directors.
Finally, Table 3 presents a comparison of small-world networks identified in a range of
existing studies and allows us to assess “how small” the networks in the Irish biotech
industry are. The small-world network statistics of the Irish biotech industry are compared
with comparable small-world statistics presented in the Casper and Murray (2005) study of
past career affiliation networks (i.e. networks formed by previous employment) among
scientific employees in two European biotechnology clusters, Cambridge, UK, and
Munich, Germany. Comparison across the networks illustrates once again the presence
of strong small-world characteristics within the Irish Biotech informal director network
and the network of companies connected via directors, as well as the lesser degree of
Table 2. Irish biotech industry researcher and companies (via patents) network statistics
Variable Researchers Companies
Density
Density (for all researchers/firms) 0.163 0.041
Total no. of ties 16,110 64
Average no. of ties (between those connected) 52.5 2.78
Clustering
Cluster coefficient 0.975 0.439
Random cluster coefficient 0.570 0.099
Path length
Average path length among those connected 2.091 2.256
Random average path length 2.013 3.264
Notes: No. of researcher: 315; connected researchers: 307; No. of firms (that have registered patents): 40;
connected firms: 23.
Actual Knowledge Flow in the Irish Biotech Industry 1119
D
ow
nl
oa
de
d 
by
 [M
ay
no
ot
h 
U
ni
ve
rs
ity
 L
ib
ra
ry
] a
t 0
7:
23
 2
5 
M
ay
 2
01
5 
clustering in the formal network of Irish biotech researchers and the network of Irish
biotech companies via patents.
Although not relevant to the social network analysis exercise, the data set contains
spatial data that anticipate one theme of the discussion of the actual knowledge flows in
the following section. The knowledge networks are clearly not bounded by national
borders. The formal network of investigators (patents) involves both local and non-local
actors. In Figure 2, the light-shaded circular nodes denote investigators located in
Ireland and the dark-shaded circular nodes denote investigators located in other countries.
Many companies owned patents that involved only Irish-based investigators. At the same
time, 35% of the companies owned at least one patent that was linked to foreign-based
investigators, although only 10 companies and 4 universities owned at least one patent
that was linked to both local and foreign-based investigators. The informal network of
company directors is far less global in character. Only a small number of Irish companies
have a non-Irish director on their board, although quite a number of Irish directors hold a
directorship of a company based abroad.
Actual Knowledge Flows
The social network analysis provides insights into the structure of the networks in question
and their ability to support knowledge flow. However, the structures are only suggestive of
knowledge flow. This section gives an account of the amount and strategic importance of
the knowledge that actually flows through the networks in the Irish biotech industry, the
paths involved and how the flows are influenced by network and knowledge character-
istics. To answer these questions in relation to the two focal networks, interviews were
conducted with members of the two networks. The interviewees were first shown the
sociograms and invited to provide information regarding the knowledge flows (operating
though the network) with directly (one step removed) and indirectly (multiple steps
removed) linked firms and institutions. The findings are summarized in Table 4.
The interviews reveal that the two particular networks are poorly exploited, although to
different extents. With respect to the formal network of investigators (patents), we found
no evidence of companies obtaining knowledge from either the directly or indirectly
linked companies (resulting from this particular network). In line with expectations
Table 3. A comparison of small-world network statistics
Network
Path length Clustering
Actual-to-random
ratio for:
Actual Random Actual Random Length Clustering
Irish biotech directors 3.538 3.127 0.948 0.039 1.131 24.31
Irish biotech companies (via
directors)
2.912 4.111 0.669 0.062 0.708 10.79
Irish biotech researchers 2.091 2.013 0.975 0.570 1.039 1.711
Irish biotech companies (via patents) 2.256 3.264 0.439 0.099 0.691 4.434
Cambridge biotech career affiliationa 3.701 2.312 0.855 0.126 1.601 6.786
Munich biotech career affiliationa 3.578 2.085 0.835 0.148 1.716 5.642
aCasper and Murray (2005).
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based on the social network analysis, the informal network of directors involves a greater
amount of knowledge flow, although the intensity of the flow depends on the type of
knowledge and geographical content of the knowledge content. In terms of the type of
knowledge, apart from one case, the flows do generally not involve technical knowledge
concerning the directly linked firms. In fact, three interviewees pointed out that they had
signed confidentiality agreement which prevented them from divulging strategic infor-
mation about their company to other companies.
The network of directors played a more important role in relation to know-who type and
general business knowledge, although the geographical content of the knowledge is a
factor here. All interviewees stated that their firms had received valuable knowledge of
this type from their directors. However, only one of the interviewees argued that the
link with the directorship network played a significant role in the identification of, and/
or introduction to, relevant actors in the Irish market. On the other hand, interviewees
pointed out that directorship networks do play a more important role at the international
scale. Six of the interviewed companies have corporate interlocks with firms outside of
Ireland and these are frequently used to obtain information about firms or markets
abroad. “If this was a European analysis or a global one, then it would be much more
likely that I would be skipping through directors. Because it is not my local area, I
would rely far more heavily on those fellow directors in the US to point me in the right
direction” (Interview biotech company).
Apart from the firms linked by the two networks, the interviewed companies did obtain
knowledge from other local firms. To investigate the extent and character of the overall
knowledge flow, companies were asked to provide information about the companies or
institutions they had turned to for either technological advice or know-who/market/
general business type knowledge during the last 5 years. Here we found evidence of
more substantial knowledge flows. Here too, the type of knowledge and type of
network had an effect on the extent of the knowledge flow and its path.
With respect to technical advice all interviewed companies had been in contact with
between three and nine other Irish companies/institutions. Universities accounted for
58% of these contracts. All interviewed companies had technology-related contact with
several Irish universities and all universities were mentioned by at least two respondents.
Table 4. Level of exploitation of the two focal networks for different types of knowledge
Single step Multi-step
National International National International
Network of investigators (formal)
Technical knowledge 2 2 2 2
Know-who knowledge n.a. n.a. 2 2
Market/business knowledge 2 2 2 2
Network of directors (informal)
Technical knowledge 2 2 2 2
Know-who knowledge n.a. n.a. 2 +
Market/business knowledge 2 + 2 +
Notes: The symbols in this table are only indicative of the intensity of the different types of information flow. “2”
denotes limited or no exploitation; “+” denotes substantial exploitation.
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However, in all but two cases, the amount of technical advice or knowledge flow was very
limited. These links involved relatively standard service provision such as analytical
services, clinical trial work by clinical research organizations and so forth. It is debatable
whether this can be considered knowledge flow. In fact, interviewees themselves
expressed unease with linking these types of contact with knowledge flow. In addition,
in most cases, the strategic importance is limited. The average score for the strategic
importance of the cases was 2.5 on a five-point Likert scale.
With respect to know-who type knowledge, we found evidence of networks facilitating
the identification of relevant actors. However, the geographical content of the knowledge
was an important factor here. The number of instances of companies intentionally consult-
ing other local companies for know-who/market type knowledge concerning the local
business environment was relatively small. Interviewees typically mentioned only one
or two such cases. However, again all interviewees expressed that the networks did
play a more important role in obtaining know-who type knowledge about actors in
other countries (quantitative data on such links were not collected).
The limited level of multi-step flows of know-who type knowledge concerning the Irish
business environment does not mean that the local networks are not exploited or not valu-
able. Rather, the limited level of such flows reflects the fact that actors are generally very
well informed about and connected to the Irish scene and do not need to consult the
network for know-who type information about, or introductions to, actors in Ireland.
The level of personally embedded know-who type knowledge is, in fact, for a large
part, the result of a long-term participation in a range of local networks. Interviewees
pointed out that they personally knew and could directly (single step) contact a large
part of the Irish biotech scene on the basis of these relations.
Again, the networks are extensively exploited to facilitate the multi-step flow of know-
who and business type knowledge concerning other countries. Informal network relations
were by far the dominant type of network supporting this type of knowledge flow. A range
of networks are at play, including professional networks of individuals (which include
former formal relations that had evolved into informal relations), student networks and
social networks. Most important are the personal professional networks, built up over
years, linking former and current colleagues and commercial contacts. “The most impor-
tant channel is related to people moving on” (Interview biotech company). During their
careers, individual actors come into contact with a large section of the Irish biotech indus-
try. Although some of the relations are closer than others, most facilitate contact and infor-
mation flow over a long period. As one interviewee put it: “We were collaborating with
[this company] on some of their technology. That is 10 years ago. But it is still easier
to pick up the phone, asking for somebody by name, if you have met the person” (Inter-
view biotech company). Another important network is formed by university alumni. “Uni-
versity College Dublin (UCD) is part of the extended diaspora from my Trinity College
days. So, colleagues from Trinity College who are now based at UCD. We retain a
fairly open channel with them and indeed other post-docs” (Interview biotech company).
The informal network of company directors is one part of this broader set of partly over-
lapping informal networks linking the Irish biotechnology firms. The directorship network
is a relatively small element in the overall informal network constellation. Other informal
networks, notably the professional networks of the individuals and network of university
alumni involve many more relations and therefore play a far greater role in knowledge
flow.
1122 C. van Egeraat & D. Curran
D
ow
nl
oa
de
d 
by
 [M
ay
no
ot
h 
U
ni
ve
rs
ity
 L
ib
ra
ry
] a
t 0
7:
23
 2
5 
M
ay
 2
01
5 
Conclusions
This paper sets out to make both a theoretical and a methodological contribution to the
field of innovation network research. The theoretical contribution focuses on two research
questions: (1) What are the structural characteristics of knowledge and innovation net-
works in the Irish biotech sector and are these conducive to knowledge flow? (2) How
much knowledge actually flows across these networks, in what way and how is
the level of actual knowledge flow influenced by the types of network and knowledge
in question?
The social network analysis conducted in this paper shows that both the formal network
of researchers and the informal network of company directors have small-world character-
istics, suggesting that they are conducive to knowledge flow. In line with the expectations,
the structure of the informal network is more conducive to knowledge flow than the struc-
ture of the formal network.
The results of the subsequent analysis of actual knowledge flows are surprising, at least
at first glance. The interviews show that the two particular networks are poorly exploited,
although the informal network is somewhat better exploited than the formal network.
However, to a large extent, this can be brought back to the specific networks under con-
sideration. The interview data about knowledge flows between all actors in the Irish bio-
technology industry (irrespective of whether or not these actors were identified in the
sociograms related to the two focal networks) provide evidence of more substantial knowl-
edge flows.
In line with the postulations outlined in the second section, the extent of the knowledge
flows and the path of the flows depend on the type of network and the type of knowledge.
In terms of the type of network, informal relations and networks dominate as a medium for
knowledge flow. In relation to the disagreement as to the salience or importance of the
informal exchange for the competitiveness of firms (Dahl & Pedersen, 2004), as outlined
in the second section, our findings suggest that the informal exchange can involve knowl-
edge of significant commercial or strategic value.
As regards type of knowledge, this paper stresses the importance of distinguishing
between types of knowledge flow and expands the typology of knowledge flows developed
by Asheim et al. (2007). This expanded typology allowed us to undertake a detailed
assessment of each type of knowledge flow in both the formal and informal knowledge
networks under consideration in this study. We found limited evidence of technical knowl-
edge flow and that the technical knowledge which was exchanged was of limited strategic
value. The networks were more intensively exploited for the know-who/market type
knowledge. Where the extant literature provides little attention to the geographical
content of the knowledge and the path of the flow, this paper identifies these as important
distinguishing factors. For example, where know-who market type knowledge concerns
knowledge about Ireland, the flows tend to be a single step, simply because the large
number of direct local network relations of the actors. We did find more evidence of mul-
tiple-step flow of know-who knowledge about foreign locations.
As regards the methodological contribution, the results of this paper raise questions
about the application of social network analysis in innovation studies. Notably, innovation
networks identified through social network analysis using patent data may involve rela-
tively little actual information flow, certainly after these networks are devolved. In
addition, in contrast to the implicit assumption of the small-world analysis, the results
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of this study suggest that the much knowledge, notably technical knowledge, flows not
beyond one or two steps.
The insights into the structural characteristics of the knowledge and innovation net-
works and the actual level of knowledge flow of the Irish biotechnology sector yield
some lessons regarding network policy. First, rather than focusing on individual formal
networks, network policy in the Irish biotech industry should involve the entire social
worlds of firms—the entire constellation of informal social networks, including pro-
fessional networks of individuals, university alumni and social networks.
Secondly, the Irish Biotech sector appears to be intensively networked and the structures
of the networks are conducive to knowledge flow. The focus of network policy may there-
fore be less on the establishment/expansion of networks and more on the better exploita-
tion and use of existing networks.
Thirdly, existing informal networks in the biotech industry involve limited technical
knowledge flow and diffusion. This is partly due to efforts to protect firm-specific
assets and intellectual property. There is, however, scope to better exploit the informal
network for the flow of less-sensitive technological knowledge. One could think of a
national online science forum for biotechnology scientists and technicians. Here biotech-
nology scientists and technicians in companies and universities could ask for advice about,
and interactively discuss, scientific and technical problems.
Fourthly, network policy can play a particularly valuable role in stimulating the flow of
know-who and business/market type knowledge related to foreign locations. One sugges-
tion would be to establish an online forum for regional actors (in universities; research
institutions and private enterprise) to consult each other on a reciprocal basis about the
location of non-local actors, sources of knowledge and relevant intellectual property.
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Notes
1. The formal vs. informal distinction is closely related to the distinction between structural social capital
and relational social capital as recognized by Nahapiet and Ghoshal (1998) and applied in the context
of the Cambridge biotech industry by Myint and Vyakarnam (2004).
2. The Fame data set provides ownership, governance and financial data on UK and Irish companies. For
further details, see www.bvdinfo.com/Products/Company-Information/National/Fame.
3. This data set also contains information on the founders of each company, serial entrepreneurs who form
numerous companies and spin-off companies. The database also identifies whether these spin-off compa-
nies emerged from existing private companies or universities. The date of establishment of all spin-offs
and existing companies is also included in the data set.
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4. On the basis of the pilot interview, it was decided to condense know-why and know-how type knowledge
into a single, category named “technical knowledge”.
5. The OECD (2006) defines biotech as the application of science and technology to living organisms, as
well as parts, products and models thereof to alter living or nonliving materials for the production of
knowledge, goods and services. In order to narrow the definition to “modern” biotech, the OECD
employs a list-based definition that includes various techniques and activities: synthesis, manipulation
or sequencing of DNA, RNA or protein; cell and tissue culture and engineering; vaccines and immune
stimulants; embryo manipulation; fermentation; using plants for cleanup of toxic wastes; gene therapy;
bioinformatics, including the construction of databases, and nanobiotech.
6. See www.hea.ie for further details.
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